InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (47 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
47
T+90 hit rate
0%
T+90 mean return
-21.4%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Catinazzo Thomas, Chief Financial Officer. Insider active across 2 companies, notably Relay Therapeutics, Inc.. In total, 65 filings have been published. Split: 0 buy · 47 sells. Total volume traded: €1.4m. Activity tracked since 30 March 2021. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations65 total
17,717 shares@ US$18.69Common StockSEC:0001193125-26-298679:0
17,717 sharesCommon StockSEC:0001193125-26-281061:0
56,323 sharesCommon StockSEC:0001193125-26-281061:1
56,323 sharesCommon StockSEC:0001193125-26-281061:2
61,563 sharesCommon StockSEC:0001193125-26-281061:3
61,563 sharesCommon StockSEC:0001193125-26-281061:4
51,560 sharesCommon StockSEC:0001193125-26-281061:5
51,560 sharesCommon StockSEC:0001193125-26-281061:6
17,717 shares@ US$12.80080.0083% mcap24.0% of flowCommon StockSEC:0001193125-26-224545
17,717 shares@ US$12.860.0084% mcap24.1% of flowCommon StockSEC:0001193125-26-224545:0
972 shares@ US$14.790.0003% mcap1.4% of flowCommon StockSEC:0001193125-26-197419:0
17,717 shares@ US$13.0117.7% of flowCommon StockSEC:0001193125-26-150044:0
1,800 shares@ US$5.220.7% of flowCommon StockSEC:0001193125-26-150044:1
1,800 shares@ US$15.002.1% of flowCommon StockSEC:0001193125-26-150044:2
12,943 shares@ US$3.003.9% of flowCommon StockSEC:0000950170-25-061366:3
1,709 shares@ US$3.170.5% of flowCommon StockSEC:0000950170-25-061366:0
981 shares@ US$3.170.3% of flowCommon StockSEC:0000950170-25-061366:1
3,558 shares@ US$3.231.2% of flowCommon StockSEC:0000950170-25-061366:2
298 shares@ US$2.840.1% of flowCommon StockSEC:0000950170-25-047725:0
33,753 shares@ US$4.6317.1% of flowCommon StockSEC:0000950170-25-011327:0
299 shares@ US$4.380.1% of flowCommon StockSEC:0000950170-24-141597:0
4,566 shares@ US$4.422.2% of flowCommon StockSEC:0000950170-24-141597:1
1,697 shares@ US$6.061.1% of flowCommon StockSEC:0000950170-24-118982:0
295 shares@ US$7.510.2% of flowCommon StockSEC:0000950170-24-110810:0
1,702 shares@ US$8.851.6% of flowCommon StockSEC:0000950170-24-088815:0
25 of 65 declarations
About Catinazzo Thomas
Catinazzo Thomas is the Chief Financial Officer of Relay Therapeutics, Inc.
